INDOCO REMEDIES
Back to Cashflow Statement
|
INDOCO REMEDIES Last 5 Year Cash Flow from Operating Activities History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Cash Flow from Operating Activities | ₹157 Cr | ₹179 Cr | ₹174 Cr | ₹82 Cr | ₹123 Cr |
What is the latest Cash Flow from Operating Activities ratio of INDOCO REMEDIES ?
Year | Cash Flow from Operating Activities |
---|---|
Mar2024 | ₹157 Cr |
Mar2023 | ₹179 Cr |
Mar2022 | ₹174 Cr |
Mar2021 | ₹82 Cr |
Mar2020 | ₹123 Cr |
How is Cash Flow from Operating Activities of INDOCO REMEDIES Trending?
Years | Cash Flow from Operating Activities | % Change | |
---|---|---|---|
Mar2024 | ₹157 Cr | -12.38 | |
Mar2023 | ₹179 Cr | 2.88 | |
Mar2022 | ₹174 Cr | 111.41 | |
Mar2021 | ₹82 Cr | -33.07 | |
Mar2020 | ₹123 Cr | - |
Compare Cash Flow from Operating Activities of peers of INDOCO REMEDIES
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
INDOCO REMEDIES | ₹3,120.5 Cr | 3.9% | 19.3% | 2.1% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹408,667.0 Cr | 1.8% | 3.4% | 7.3% | Stock Analytics | |
DIVIS LABORATORIES | ₹180,131.0 Cr | -0.7% | 3.8% | 49.3% | Stock Analytics | |
CIPLA | ₹119,745.0 Cr | -0.2% | -1.1% | -2.8% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹118,603.0 Cr | 5.8% | 8.6% | 17.3% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹105,429.0 Cr | 0.7% | -3.8% | -7.3% | Stock Analytics |
INDOCO REMEDIES Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
INDOCO REMEDIES | 3.9% |
19.3% |
2.1% |
SENSEX | -1.1% |
0.8% |
2.2% |
You may also like the below Video Courses